{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T01:21:19Z","timestamp":1793496079988,"version":"4.5.0"},"reference-count":7,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T00:00:00Z","timestamp":1627603200000},"content-version":"am","delay-in-days":332,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","prd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Parkinsonism & Related Disorders"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.parkreldis.2020.07.012","type":"journal-article","created":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T12:02:21Z","timestamp":1595419341000},"page":"68-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Subcutaneous apomorphine infusion in advanced idiopathic Parkinson's disease and agranulocytosis: a case report"],"prefix":"10.1016","volume":"78","author":[{"given":"Sakahl\u00e9","family":"Cond\u00e9","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Derost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9reng\u00e8re","family":"Debilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Lauxerois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eve","family":"Chanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franck","family":"Durif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6 Suppl 4","key":"10.1016\/j.parkreldis.2020.07.012_bib1","first-page":"S32","article-title":"Practical considerations in the use of apomorphine injectable","volume":"62","author":"Bowron","year":"2004","journal-title":"Neurology. 23 mars"},{"issue":"11","key":"10.1016\/j.parkreldis.2020.07.012_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2165\/00002512-200421110-00001","article-title":"Subcutaneous apomorphine\u00a0: an evidence-based review of its use in Parkinson's disease","volume":"21","author":"Deleu","year":"2004","journal-title":"Drugs Aging"},{"issue":"7","key":"10.1016\/j.parkreldis.2020.07.012_bib3","doi-asserted-by":"crossref","first-page":"e92","DOI":"10.1111\/ene.12149","article-title":"Major eosinophilia induced by subcutaneous apomorphine infusion: four cases","volume":"20","author":"Moisset","year":"2013","journal-title":"Eur. J. Neurol."},{"issue":"Suppl 1","key":"10.1016\/j.parkreldis.2020.07.012_bib4","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1016\/j.parkreldis.2016.11.017","article-title":"Practical management of adverse events related to apomorphine therapy","volume":"33","author":"Bhidayasiri","year":"2016","journal-title":"Parkinsonism Relat Disord. dec"},{"issue":"5","key":"10.1016\/j.parkreldis.2020.07.012_bib5","doi-asserted-by":"crossref","first-page":"e122","DOI":"10.4158\/EP12395.CR","article-title":"Recurrent neutropenia due to dopamine agonists in a patient with microprolactinoma","volume":"19","author":"Butt","year":"2013","journal-title":"Endocr. Pract.: September"},{"key":"10.1016\/j.parkreldis.2020.07.012_bib6","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.parkreldis.2015.02.002","article-title":"Levodopa- induced neutropenia","volume":"21","author":"Cordano","year":"2015","journal-title":"Parkinsonism Relat Disord avr"},{"issue":"2","key":"10.1016\/j.parkreldis.2020.07.012_bib7","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2257.2002.00437.x","article-title":"Nonchemotherapy drug-induced agranulocytosis: experience of the Strasbourg teaching hospital (1985-2000) and review of the literature","volume":"2","author":"Andr\u00e8s","year":"2002","journal-title":"Clin Lab Haematol. avr"}],"container-title":["Parkinsonism & Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020306490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1353802020306490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:19:16Z","timestamp":1761178756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1353802020306490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":7,"alternative-id":["S1353802020306490"],"URL":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.07.012","relation":{},"ISSN":["1353-8020"],"issn-type":[{"value":"1353-8020","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subcutaneous apomorphine infusion in advanced idiopathic Parkinson's disease and agranulocytosis: a case report","name":"articletitle","label":"Article Title"},{"value":"Parkinsonism & Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.parkreldis.2020.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}